Tech Transfer Central

From Strategic Plan to Execution: Charting a Course for Your Start-Up’s Exit Event

Format: On-Demand Video/Transcript, or DVD
Originally presented: Wednesday, October 6, 2021

Twitter Facebook Linkedin Pinterest Email
Price: $197
order button view cart

Even at the point of forming a university-based start-up company, future investors want to know your exit plan for the company. Whether by merger or acquisition, an initial public offering (IPO), a management buyout, or SPAC (special purpose acquisition company), charting your exit strategy is a critical aspect of any start-up’s strategic plan.

Not every type of exit is appropriate for every business. Each strategy is unique and holds specific regulatory and accounting requirements that should be considered when forming and growing the company. This insightful webinar will help you navigate the twists and turns to make an informed decision on the exit strategy that is right for you and your company.

From Strategic Plan to Execution: Charting a Course for Your Start-Up's Exit Event

Join expert attorney Christopher T. Turek of Greenberg Traurig’s Corporate Practice in the firm’s Washington, D.C. office, and entrepreneur and nationally recognized authority on technology transfer venture creation Gerard Eldering, CEO of Perfusion Medical, when they delve into exit planning, the types of exits and the pros and cons of each, determining the right time to exit, and much more.

Here’s a quick look at the agenda details:

  • Why do so many entrepreneurs focus on the exit?
  • What is the reality of exits – statistics on acquisitions, IPOs, price ranges, age of company
  • Types of exits
    • “Aqui-hires”
    • Lifestyle/ Mature company sales – multiples of EBITA
    • Big exits – acquisitions and IPOs
    • Distressed/bankruptcy
  • Types of Buyers
    • Strategic
    • Private Equity
  • Being prepared:
    • Fundamentals – revenue, profit, IP protection, growth rate
    • Key milestones – FDA, major customer
    • Paperwork – the details
    • Positioning and relationships
  • What is involved in a transaction?
    • Finding a buyer
    • Due Diligence
    • Preparing and negotiating legal documents
    • Signing and Closing a Deal
    • Post-Closing (What happens next?)
  • How long does the process take and what kinds of advisors do I need to engage?
  • Real-world examples

Meet your faculty:

Christopher T. TurekChristopher T. Turek is a member of Greenberg Traurig’s Corporate Practice in the firm’s Washington, D.C. office.  Chris represents technology and growth companies, private equity firms and venture capital funds in a broad range of complex corporate and transactional matters, including mergers and acquisitions, joint ventures, spinout and technology transfers, public and private capital market financings, commercial transactions, as well as general corporate and securities law matters. Chris regularly advises institutional investors in venture capital and private equity financing and sale transactions, including numerous complex cross border transactions. Chris has a wide breadth of domestic and international experience and has assisted clients in transactions in countries on almost every continent, including the United Kingdom, Australia, Sweden, Finland, Germany, India, France, South Africa, Switzerland, Panama, Japan, South Korea, Israel and Poland.

Gerard ElderingGerard Eldering is an experienced entrepreneur, a nationally recognized authority on technology transfer venture creation, and currently serves as the CEO of Perfusion Medical.  Since becoming an entrepreneur in 2007 Gerard has participated in the formation of more than 12 tech startups, raised more than $4 million in seed funding and led the successful turn around and sale of a technology consulting firm. Gerard is an expert at university licensing, startup formation and company operations. He has in-depth experience identifying promising university technology, launching startup companies, securing seed funding and building entrepreneurial management teams. Prior to 2007 he founded and served as Director of the Technology Transfer Office (TTO) at The MITRE Corporation. Gerard holds an MBA and is a registered patent agent.

Our Guarantee of Quality and Value

We stand 100% behind the quality and value of our products. If you are dissatisfied, simply let us know and we will send you an immediate refund for your entire order -- no questions asked.

order button
view cart

Click here for a printable order form